Search
Sulbentine
go.drugbank.com/drugs/DB13671ExperimentalCategories: Antifungals for Topical Use, Antifungals for Dermatological UseMVC-COV1901
go.drugbank.com/drugs/DB15854InvestigationalThe vaccine candidate contains a perfusion form of the SARS-Cov2 recombinant spike protein. … Medigen has combined forces with Dynavax, which offers an advanced adjuvant, CpG 1018 (also known as [ISS-1018]), for use with its vaccine.
Arbaclofen Placarbil
go.drugbank.com/drugs/DB08892InvestigationalOn May 20th, 2013, XenoPort announced plans to terminate the development of Arbaclofen Placerbil for the treatment of multiple sclerosis. … It was discovered, and has been patented by XenoPort as a new chemical entity with an improved pharmacokinetic profile compared to baclofen, which allows for sustained release properties.
Cannabinor
go.drugbank.com/drugs/DB05048ExperimentalCannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
ATX-101
go.drugbank.com/drugs/DB05780InvestigationalATX-101 (medical), sodium deoxycholate for subcutaneous injection, is being evaluated as a treatment for the reduction of localized fat deposits. … ATX-101 demonstrates a relative selectivity for fat over other tissues.
Bunamidine
go.drugbank.com/drugs/DB11501ExperimentalVet approvedBunamidine is a veterinary anti-platyhelmintic agent used for taenia infestations.
Belotecan
go.drugbank.com/drugs/DB12459InvestigationalBelotecan has been investigated for the treatment of Epithelial Ovarian Cancer.